The latest eye-related research – in small chunks
Aleksandra Jones | | Quick Read
- Scientists at Trinity College Dublin in Ireland have developed a new gene therapy with the potential to treat dominant optic atrophy (1). The approach improves mitochondrial performance in cells containing mutations in the OPA1 gene (see figure 1).
- A novel imaging technique – serial block face scanning electron microscopy – has been used to digitally reconstruct eye tissues of the outer retina, providing new understanding into age-related diseases resulting in sight loss, such as AMD (2).
- New research reveals that massive apoptosis of chandelier cells – branched neurons that can inhibit the signaling of cells in their vicinity, affecting the brain’s integration of visual information – plays a key role in binocular vision development. Blocking this apoptosis results in visual function deficiencies (3).
- Twice-a-year injection of a viscous hydrogel could replace daily eye drops or surgical treatments of glaucoma. Once in the eye, the injected polymer holds open a channel in the suprachoroidal space, allowing aqueous humor to drain and sustaining pressure reduction for four months – hopefully longer in future (4).
- Genes that increase the risk of diabetic retinopathy (DR) have been identified by a team from the University of Illinois in Chicago, USA. FLCN, which codes for the protein folliculin, reacts differently to high glucose in patients with and without DR (5).
Subscribe to The Ophthalmologist Newsletters
- DM Maloney et al., Front Neurosci, 14 (2020). PMID: 33324145.
- E Keeling et al., Int J Mol Sci, 21, 8408 (2020). PMID: 33182490.
- BS Wang et al., Neuron, [Online ahead of print] (2020). PMID: 33290732.
- JJ Chae et al., Adv Sci (2020). DOI: 202001908.
- AD Skol et al., Elife, 9 (2020). PMID: 33164750.